_gaq.push(['_trackPageview']); (function() { var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true; ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js'; var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s); })(); Free Sitemap Generator
Tuesday, August 10th, 2010 | Author: nimda | Free Sitemap Generator

Presentation of results from open-label extension study of Xenazine announced
Lundbeck Inc. today announced the presentation of results from an open-label extension study of Xenazine- (tetrabenazine) for the treatment of chorea associated with Huntington’s disease (HD). Data from this study demonstrated that after an 80-week treatment period, subjects treated with Xenazine experienced a statistically significant reduction in chorea score (p

Read more on News-Medical-Net

Concussions on the rise in college hoops
KANSAS CITY, Mo. — Diving for a loose ball during a summer pickup game, North Carolina center Tyler Zeller knocked heads with another player.

Read more on SportingNews

Originally posted 2010-03-10 21:04:11.

Tags: , , , Category: Migraine
You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
Leave a Reply » Register / Log in